Metraipolis › archive › dc_ebc4f94dbb1c

The Business of DNA Nanotechnology: Commercialization of Origami and Other Technologies — Europe PMC PMID:31963295

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/31963295
DOI
10.3390/molecules25020377
License (as archived)
solo-consultazione
Archived
2026-10-08T03:49:46.447Z
SHA-256 of the archived text
529cd2b0fe0e02aa982e311443b5858231f7e227c82c8bb4d239a7535bbe6641
Stable URL of this page
https://metraipolis.com/documento/dc_ebc4f94dbb1c

How to cite

The Business of DNA Nanotechnology: Commercialization of Origami and Other Technologies — Europe PMC PMID:31963295 — Europe PMC (en), https://europepmc.org/article/MED/31963295 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebc4f94dbb1c (Metraipolis archive dc_ebc4f94dbb1c, sha256 529cd2b0fe0e02aa982e311443b5858231f7e227c82c8bb4d239a7535bbe6641)
BibTeX
@misc{dcebc4f94dbb1c,
  title = {The Business of DNA Nanotechnology: Commercialization of Origami and Other Technologies — Europe PMC PMID:31963295},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/31963295},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebc4f94dbb1c; sha256 529cd2b0fe0e02aa982e311443b5858231f7e227c82c8bb4d239a7535bbe6641},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/31963295. Agents can read the archived copy with the MCP tool read_document.